Hepatitis D
Husa, P.; Linhartová, A.; Nemecek, V.; Husová, L.
Acta Virologica 49(4): 219-225
2005
ISSN/ISBN: 0001-723X PMID: 16402678 Document Number: 590755
Hepatitis D virus (HDV) is a small, RNA-containing virus that requires the concomitant presence of Hepatitis B virus (HBV) in an obligate manner for its survival and pathogenicity. HDV infection is very uncommon in Czech Republic. The results of antiviral therapy of hepatitis D patients are not satisfactory. Alpha-interferon (alpha-IFN) in high doses (9-10 MU three times a week for 12 months) is usually recommended.
Document emailed within 1 workday
Related Documents
Ari, A. 1977: Epidemiology of viral hepatitis: hepatitis A, hepatitis B and unclassified hepatitis Turk Hijiyen Ve Deneysel Biyoloji Dergisi. Turkish Bulletin of Hygiene and Experimental Biology 37(1): 71-86Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
El-Sayed, N.M.; el-Halawani, T.A. 1995: Comparative study of serum and salivary hepatitis B surface antigen and hepatitis C antibodies among patients infected with hepatitis B or C virus Egyptian Dental Journal 41(3): 1305-1312
Kondo, M.; Sueta, S.; Oida, E.; Tagawa, M. 2015: A case report of hepatitis B virus reactivation in a hepatitis B core antibody-positive, hepatitis B surface antigen-negative hemodialysis patient Nihon Jinzo Gakkai Shi 57(8): 1363-1368
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Reuter, G.áb.; Szucs, G.ör. 2004: Is endemic hepatitis e infection present in developed countries?--Accumulating information about the hepatitis e virus and hepatitis e infection Orvosi Hetilap 145(51): 2555-2561
Perrillo, R.P.; Brunt, E.M. 1991: Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen Annals of Internal Medicine 115(2): 113-115
Guido, M.; Rugge, M.; Colombari, R.; Cecchetto, A.; Scarpa, A.; Cadrobbi, P. 1998: Prompt hepatitis C virus suppression following hepatitis B virus superinfection in chronic untreated hepatitis C Italian Journal of Gastroenterology and Hepatology 30(4): 414-417
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Lunel, F. 1992: Hepatitis C virus: the virus responsible of the majority of non a non B hepatitis. 2: Epidemiology of Hepatitis C Gastroenterologie Clinique et Biologique 16(6-7): 526-536
Yao, C.; Zhou, Y.; Xie, D. 1998: An analysis of hepatitis G virus infection status in various cases of hepatitis in Guangdong area Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 12(4): 330-332
Todd, C.S.; Nasir, A.; Stanekzai, M.R.; Bautista, C.T.; Botros, B.A.; Scott, P.T.; Strathdee, S.A.; Tjaden, J. 2010: HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities Aids 24(Suppl 2): S69-S75
Alexander, M.; Scholz, V.; Wenzel, H. 1973: Course controls of hepatitis B antigen during and after acute virus hepatitis in the years 1964 to 1972 Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 977-979
Grob, P.J.; Negro, F.; Renner, E.L. 2000: Hepatitis C virus infection. Overview. SEVHEP (Swiss Experts on Viral Hepatitis) Praxis 89(40): 1587-1604
Hu, Z.; Teng, H.; Han, M. 1994: Observation on prevention of hepatitis B virus transmission from mother to baby by hepatitis B vaccine Zhonghua Liu Xing Bing Xue Za Zhi 15(6): 346-348
Rzeszowska, G.; Mazurek, E.; Mierzejewska, I.; Fijałka-Rymar, M.; Ignaciuk, A. 1987: Titers of selected indicators of hepatitis B in the blood of patients with acute viral hepatitis Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 42: 89-94
Jarrett, W.F.; O'Neil, B.W. 1985: A new transmissible agent causing acute hepatitis, chronic hepatitis and cirrhosis in dogs Veterinary Record 116(24): 629-635